GI Genius Module 300

by Medtronic  · Based in Ireland → — The GI Genius™ intelligent endoscopy module is the first-to-market, computer-aided polyp detection system powered by artificial intelligence.
Colorectal Surgery Gastroenterology Oncology

Contact vendor for pricing
Regulatory Status Disclosed

Overview

The GI Genius™ intelligent endoscopy module, including the Module 300, is a groundbreaking, first-to-market computer-aided polyp detection system powered by artificial intelligence (AI). Developed by Cosmo Artificial Intelligence – AI and globally distributed by Medtronic, it is designed to assist endoscopists in real-time detection of colonic mucosal lesions, such as polyps and adenomas, during standard white light endoscopy examinations.

The system works by continuously scanning the video stream from the endoscope camera. When it identifies a potential lesion, it automatically highlights the abnormality with a green box and provides a short, low-volume audible signal, enhancing the physician’s visualization and improving the thoroughness of the examination. Studies have shown that the GI Genius™ module can increase the Adenoma Detection Rate (ADR) by up to 14.4%, contributing to earlier detection and improved patient outcomes in the fight against colorectal cancer.

The GI Genius™ module is compatible with all standard white light endoscopes and is intended to be used as an adjunct to colonoscopy procedures, not as a replacement for clinical decision-making or endoscopist assessment.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time AI-assisted polyp and lesion detection during colonoscopy
  • Computer-aided visualization enhancement for mucosal lesions
  • Increases Adenoma Detection Rate (ADR) by up to 14.4%
  • High sensitivity rate of 99.7% with less than 1% false positives
  • Compatible with all standard white light endoscopes
  • Identifies and marks abnormalities with a green box and audible signal
  • Aids in detecting polyps of various sizes, shapes, and morphologies
  • Supports early detection of colorectal cancer

Use Cases

  • Colorectal cancer screening and surveillance colonoscopies
  • Real-time detection of colonic mucosal lesions (polyps, adenomas)
  • Improving endoscopist performance and accuracy in lesion detection
  • Reducing the risk of missed polyps during endoscopic examinations
  • Enhancing patient care and outcomes in gastrointestinal disease management

What Physicians Need to Know

GI Artificial Intelligence
Medtronic offers Gastrointestinal Artificial Intelligence within its product offerings.

Details

Category Gastroenterology AI
Pricing Contact vendor for pricing
DeploymentHardware and software module integrated as an adjunct to standard white light endoscopy systems.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated

The sale, distribution, and the use of the GI Genius™ system are restricted to prescription use in accordance with 21 CFR 801.109.

Integrations
EHR Not specified
Specialties Colorectal Surgery, Gastroenterology, Oncology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-07-25K241887 510(k)GI Genius™ Module 300

What the Web Says

The Medtronic GI Geniusu2122 Module 300 is an AI-powered endoscopy system designed to assist physicians in detecting colorectal polyps during colonoscopies. It functions as a real-time second observer, enhancing the video stream with graphical markers around areas of interest identified by its computer-aided detection (CADe) algorithm. The system has been shown to significantly improve adenoma detection rates (ADR), which is crucial for preventing colorectal cancer.

Overall: Positive

Strengths

  • Increases adenoma detection rate (ADR) significantly, with studies showing up to a 14.4% absolute increase and a 12% relative increase.
  • Reduces the miss rate of colorectal polyps and adenomas by approximately 50% compared to standard colonoscopy.
  • Identifies small, flat, and subtle polyps that might otherwise be missed by the human eye.
  • Provides real-time analysis and flags potential problem areas without modifying or delaying the endoscopy video stream.
  • Universally compatible with major existing brands of endoscopic processors (Olympus, Fujifilm, Pentax).
  • Can help decrease the risk of interval colorectal cancer; each 1% increase in ADR reduces this risk by 3%.

Limitations

  • May not significantly improve the detection of advanced adenomas or sessile serrated lesions.
  • Its impact may be less significant among highly experienced endoscopists in real-world scenarios compared to controlled study conditions.
  • There is a concern about potential over-reliance on the AI system and a possible drop in ADR if physicians become accustomed to using it and then it's removed.
  • Can lead to a small increase in the amount of healthy tissue biopsied.
  • The technology can be expensive, leading some centers with already good ADRs to not yet incorporate it.
  • Some physicians note that the AI can occasionally miss polyps or highlight areas that are not a concern.

Based on reviews from: Medtronic, PMC, Medical Device Network, Newsroom | Medtronic, UCHealth, Colon Cancer Foundation, The AdventHealth Blog, ENDOSCOPY (Shria Kumar, MD, MSCE and Gottumakkala S. Raju, MD, FACG, FASGE), PubMed, GI Alliance, Mayo Clinic School of Continuous Professional Development, University Hospital, PR Newswire, Reddit (r/Gastroenterology, r/science)

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate GI Genius Module 300

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Stock Titan
Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates
Cosmo Pharmaceuticals reported strong preliminary unaudited 2024 results, including u20ac185 million in non-recurring revenues from Medtronic and FDA 510(k) clearance for the GI Geniusu2122 Module 300 hardware. The GI Geniusu2122 installed base continued to grow in 2024, and the module 300, powered by Nvidia IGX, received FDA 510(k) clearance.
2025-01
Nasdaq
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
Cosmo Pharmaceuticals announced the smooth rollout of the GI Geniusu2122 Module 300 across customer sites, confirming its robustness and scalability. The company also initiated a clinical usability study integrating the Medtronic GI Geniusu2122 AI endoscopy module with Apple Vision Pro during live colonoscopy procedures.
2026-01
Innolitics
Q2 2026 AI/ML FDA Clearances and De Novos
The FDA authorized 86 AI/ML devices in Q2 2026, including the GI Geniusu2122 Module 300 (GGM300-US) for Gastroenterology/Urology, which received 510(k) clearance. This report highlights the continued growth of AI in medical devices, with radiology still dominating but other specialties emerging.
2026-07
Medtronic News
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care.
Medtronic announced innovations and collaborations at the Genius Summit 2024, highlighting the GI Geniusu2122 Module 300 as an open compute engine for AI applications built on NVIDIA IGX. The flagship application, ColonPROu2122, aims to reduce miss rates in colorectal cancer screening through polyp detection and characterization.
2024-04
TMX Newsfile
Cosmo Achieves Robust Financial Performance in H1 2024 and Confirms Its Full Year Guidance
Cosmo Pharmaceuticals reported strong H1 2024 results, including a $100 million upfront payment from Medtronic related to an expanded AI-driven partnership. The new GI Geniusu2122 module 300, powered by Nvidia IGX, has been submitted to the FDA for clearance.
2024-07
Public Technologies (PUBT)
Cosmo Pharmaceuticals Half-Year Report 2024
Cosmo Pharmaceuticals' Half-Year Report 2024 highlights the submission of the new GI Geniusu2122 module 300, powered by Nvidia IGX, to the FDA for clearance. The report also notes the continued growth of the GI Geniusu2122 installed base and the development of additional features.
2024-06
RegWatch
FDA 510(k) Clearance: GI Geniusu2122 Module 300 (GGM300-US);ColonPROu2122 US (CPRO403S-US)
Cosmo Artificial Intelligence - Ai, Ltd. received FDA 510(k) clearance (K261369) for GI Geniusu2122 Module 300 (GGM300-US) and ColonPROu2122 US (CPRO403S-US) on May 29, 2026. The product is classified under Gastroenterology, Urology with product code QNP.
2026-05
RevMed
GI Geniusu2122 Module 300 (GGM300-US)
RevMed lists the GI Geniusu2122 Module 300 (GGM300-US) by LINKVERSE SRL, describing it as a GI Geniusu2122 system with ColonPROu2122 software. It is categorized under Gastroenterology & Urology as a Gastrointestinal Lesion Software Detection System.
unknown

Videos

Product demos, reviews, and walkthroughs for GI Genius Module 300.

Loading videos...

View all on YouTube

Frequently Asked Questions

The provided text mentions 'Gastrointestinal Artificial Intelligence' as a product category under Medtronic's offerings. However, specific details on the usage of the GI Genius™ Module 300 are not available in the provided official website text.
The provided official website text does not contain information regarding the compliance requirements for the GI Genius™ Module 300.
The provided text lists 'Gastrointestinal Artificial Intelligence' as a product category, but it does not detail specific alternative products to the GI Genius™ Module 300 within this category.
The official website text provided does not include any information about the pricing of the GI Genius™ Module 300.
The provided official website text does not specify any limitations of the GI Genius™ Module 300.

Related Tools

GHAPP
GHAPP
Gastroenterology AI
GHAPP is a digital learning hub dedicated to providing educational programs and resources for Advanced Practice Providers (APPs) in gastroenterology and hepatology.
Deep Capsule® (Deep Capsule US)
Digestaid - Artificial Intelligence Development SA
Clinical Decision Support & Reference
Deep Capsule® is an AI-powered tool by Digestaid for analyzing capsule endoscopy videos, designed to enhance the detection and differentiation of small bowel lesions and reduce review time for clinicians.
ColonPRO 4.0 (CPRO40.US)
Cosmo Artificial Intelligence - AI
Gastroenterology AI
Cosmo Artificial Intelligence - AI is a life sciences company focused on MedTech AI, dermatology, and gastroenterology, developing innovative products and partnering globally to empower patients and healthcare professionals through technology.
ColonPRO US
Cosmo Artificial Intelligence - Ai, Ltd.
Clinical Decision Support & Reference
ColonPRO™ US is an AI-powered device that assists gastroenterologists in real-time polyp detection and characterization during colonoscopy.
Instrument Exit Point on Touch Surgery Aide
Covidien, LLC
Gastroenterology AI
Instrument Exit Point on Touch Surgery™ Aide is an AI-powered surgical guidance tool for precise instrument placement in gastrointestinal and urological procedures.
G-EYE Colonoscope
SMART Medical Systems
Gastroenterology AI
The G-EYE® Colonoscope is a medical device developed by SMART Medical Systems, specializing in gastroenterology and gastrointestinal endoscopy. It is designed to assist in colonoscopy procedures. This device is intended for use by gastroenterologists and other medical professionals performing colonoscopies in clinical settings. It integrates into the existing clinical workflow of colonoscopy. Notable capabilities of […]

See all Gastroenterology AI tools →

More in the GI Genius line

GI Genius GI Genius Module 100 GI Genius Module 300 (this page)

More from Cosmo Artificial Intelligence – AI

ColonPRO 4.0 (CPRO40.US)
Cosmo Artificial Intelligence - AI
Gastroenterology AI
Cosmo Artificial Intelligence - AI is a life sciences company focused on MedTech AI, dermatology, and gastroenterology, developing innovative products and partnering globally to empower patients and healthcare professionals through technology.
ColonPRO 4.0 (CPRO40S-US)
Medtronic
Gastroenterology AI
ColonPRO™ 4.0 is an FDA-cleared, AI-powered computer-assisted detection system that integrates with standard colonoscopy equipment to help endoscopists identify colonic polyps and adenomas in real-time, improving detection rates during screening and surveillance procedures.
ColonPRO US
Cosmo Artificial Intelligence - Ai, Ltd.
Clinical Decision Support & Reference
ColonPRO™ US is an AI-powered device that assists gastroenterologists in real-time polyp detection and characterization during colonoscopy.
GI Genius
Medtronic
Gastroenterology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-16 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.